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1924-761 A New Non-lnvssive Method for Detection and 
Assessment of Aortic Regurgitation During 
Routine Blood Pressure ReP, ordinge 
Todd J. Brinton, Tsui-Lieh Hsu, Oi-Ung Kwan, Chun-Pang LJu, Mau Song 
Chang, Shiu-Shin Chio, Anthony N. DeMada. Veterans Hospital, Taipei, 
Taiwan, University Of California, San Diego, CA 
Recently, we developed an nsci,ometric uff technique (CUFF} to non- 
invssively derive arterial pressures and waveforms. Using this method we 
observed a unique pattern of pressure oscillations (PC)) in apt with severe 
aortic regurgitation (AR). To further define the potential mechanism Of this 
phenomenon, and its value in the detection and assessment of AR, we por- 
fom~ed clinical and modeling studies. CUFF w~s performed in 10 normal (N) 
and 15 pts in whom AR was documented and semi-quantitated by echo. In 
10 N, and all 5 mild AR pts, a bell shaped distribution of PO was observed 
from supra-systotio t  sub-diastolic uff pressure (top figure). However, all 10 
pts with grade III (severe) AR exhibited a phasic alteration ot PO conform- 
ing to a resonance pattern (bottom figure). Ta test the hypothesis that this 
phenomenon represented a ventricuisr-vascufar fluid mechanics interaction 
produced by AR, we utilized a simple amplitude modulation model (Wl = 
incident, W2 = reflect/on) and found that the pattern could be reproduce~, at
specific amplitudes and frequencies. 
Thus, CUFF recordings of adedal pressure exhibit a marked resonance 
pattern in lots with severe AR, likely due to vantdcular-vascular fluid mechan- 
ics interaction. This phenomenon should be useful in detecting and assessing 
AR dudng routine blood pressure recordings. 
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~ Deterioration In Cardiac Function Is Associated 
W'dh the Appearance of Specific HLA Antibodie~ 
After Transplantation 
Stephen H. Leech, Paul J. Mother, Howard J. EiSan, 
Valluvan Jeevanandam. Temple University Medical School, Philadelphia, PA 
The purpose of this study was to investigate the effect of HLA antibodies 
specific for mismatched donor HLA antigens appearing in the circulation 
after human odhotopfc head transplanfati0n. Although there is increasing 
evidence oi a deleterious effect of mismatched onor HLA antigens on the 
outcome of human cardiac allOgrafts, the role of HLA antibodies remains 
cantmverslal. Thus, their presence prior f0 cardiac transplantion has been 
associated not only with poor outcome by some workers but also of no 
clinical significance by others. Furthermore, their appearance after cardiac 
transplantion has also bean the subject of cenfli~ng reports, HLA antibedias 
were identified by a standard microlymphocytotoxidty technique using pan- 
els of frozen lymphocytas from normal donors who had been tissue typed. Of 
78 patients tr-,,Lnsplanted over a 12*month boded, 4 developed HLA antibod- 
Ies specific for mismatched onor HLA antigens. The first patient developed 
antibodies to HLA-A,?3 and B44, which were associated with vascular e- 
jection requidng retransplantstion within 4 months. The other patients (3) 
developed antibodies pecific for HLA-IDQ7 and experienced vadable num- 
bers of episodes of cellular ejection with negative immunofluorascance on
endomyocardial biopsy. Two of these 3 patientS died (8 and 11 months post- 
transplant) after 3 and 6 rejection episodes respectively. The one su~ving 
patient with DQ7-specific ailoantibedies has had 7 rejection episodes and 
continues to have poor venfdcular function (follow-up 13 months). We con- 
clude that i) afloantibedias specific for mismatched ~onor HLA antigens may 
have a deleterious effect on the outcome of the human cardiac allegraft and 
should be monitored closely post-transplant, and ii) that there may be special 
significance to the association with IDQ7-SpeddiC atloantibodias. 
• Myocardial Apoptosie in a Heteretopic Murine Heart 
Transplant Model of Chronic Rejection/Graft 
Vasculopalhy 
Robert Shoddy, William White, Lynda 7_han~;, Michael Traulman, 
Sherde Perkins, Elizabeth Hammond, ,J=~ne Shelby. University of Utah and 
Primary Children's Medical Center, Gait Lake City, UT 
Apoptosis (programmed ceil death) hen ~n impflcafed in myocardial raper- 
fusion injury and in experimental tlansplant rejection. One raechanism of 
apoptosis is through the interaction 01 the coil-surface hen receptor on target 
coils and the Fas ligand which is expressed on cytnfoxic i cells. To defer- 
mine whether egopt0sis occum in t'ae myocardi,zm of tranSplanted hearts, 
we examined a mudne heterOtopio 'rLeart ransplant model of chronic rejec- 
tion/graft vasculopathy (strain BI0,P, to B f0 .~)  HA~'tS harvested after 30 
days showed art intimal index of the allografts (0,F :E 0.1) (mean ~ SE) that 
was 15 to 50 times more than syngenalc grads (0.03 4- 0.01) and native 
(nentransplanted) hearts (0.01 :t: 0.01) (p < 0.00t). In situ end-labeling of 
partially degraded DNA with terminal deoxynucleetydil transferasa showed 
an increase in apoptotic oils/20 hpf in nfiografts (2.0 :t: 0.3) and Syngeneic 
grafts (3.0 :E 0.4) compared to native hearts (0.0 :E 0) (p < 0.001, ANOVA). 
Both myecytas and nonmyocytas appeared to be undergoing apoptoals. RT- 
PCR detected equal myocardial RNA signal intensity of Fas Jn allografls, 
syngenalc grafts, and native hearts (n = 4). In contrast, ailegrafts howed 
a strong signal for the Fas ligand mRNA, a signal not seen in syngeneic 
grafts or in the native hearts. We conclude that apoptosis is occurring in beth 
mudne cardiac allografts and syeganeic grafts and that Fas ligand is strongly 
expressed in routine allegrafts. Since beth atlegrafts and syngeneic grafts 
show in-situ evidence of apoptosis, but only allegrafts express Fas ligaed, 
the mechanisms of apoptosis in this model may not be exclusively related to 
Fas/Fas ligand interactions. 
~ Immunologic Characterization of 
Allegr~ff, lnfiltrating Cells in Human-Severe 
Combined Immunodeflclency Mouse Chimeras: 
Evidence for Human Effector Cell Mediation of 
Rejection 
Jin Kang, Sheri E. Baliand, Howard J. Eisen. Temple University, 
Philadelphia, PA 
Novel immunOsuppressive agents are initially tasted in experimental nimals, 
usually rodents. This approach often falls as there are substantial differences 
between human and rodent immune systems. We have developed apotential 
in vivo model of human cardian transplant rejection by mconalituting severe 
combined immunedeticisncy (SCID) mice with human peripheral blood lym- 
phecytes (PBL's) and 28 days later implanting segments of human atrial 
tissue from patients undergoing CABG surgery subcutaneously (SQ in the 
human-SCID chimeras. 7 days later lymphocyUc infiltration and myeoyte 
necrosis is seen in the cardiac allografts in these chimeras by hematoxylin 
and eoaln staining, resembling human cardiac transplast rejection. The odgin 
and type of ceils infiltrating the grafts are unknown. To determine the pheno- 
type and odgin of these cells, we administered 5 x 10 s PBUs intraperifoneally 
to 4 SCID mice and confirmed engrafting of human PBUs by flow cytometty: 
3 control SCID mice were not reconstituted. Segments of human atrial tissue 
were implanted SQ in the human-SCID chimeras and control SClD mice. 
7 days later, cardiac tissue was removed, end stained with human-specific 
anti-CO4, CO8, 11.-2 receptor (R), CO3 and ¢CAM-I antibodies. Infiltrating 
cells were seen in the reconstituted SCID mice and were pdmadly CD4+ 
and CD3+ with over 2,5% IL-2R+. No myocardial lymphocytic nfiltration or 
myocyte necrosis was seen in the control SCID mice. Endothelial ICAM- 
1 expression was seen only in ailografts in reconstituted SCID mice. We 
conclude that cells infiltrating cardiac ailngralts in human-SCID chimeras 
are human.derived, activated CD4+ similar to those seen in humar~ cardiac 
allograft rejection and that they induce allograft endothelial ctivation, 
~ - ~  0etection el  Heart Transplant Rejection by Doppler 
Tissue Imaging 
John A. Puree, Mark W. Waston, Michael F. French, Guillermo Cintren, 
Mitchell G, Davis, Hector L. Fontsnet. DNision of Cardiology, University of 
South Rotida and Tampa Genera/Hospital, Taml~, FL 
Heart tranSplant rejection (HTR) commOnly occurs in heart ransplant recipi- 
ents and requires invasive ndomyocardial biopsy (EB) for diagnosis. Thus 
far, non-invasive studies have had inadequate sensitivity to detect HTR. 
Pulsed wave Doppler tissue imaging (PWDTI) is a new non-invasive imag- 
ing modaiify capable of quantifying myocardial tissue velocities. Since HTR 
may cause disturbances in myocmdial relaxation, we pc;fomte,~ this study 
to determine whether moderate HTR results in reduced myocardial peak 
early relaxation velor'ities (PEV). Methods: 40 orthotopic heart transplant 
recipients undezwent sedal PWDTI at the time of routine surveillance EB. 10 
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patients had moderato reje~un (grade 3a or 3b), the remainder were grade 
0 to lb. All HTR patients had myocardial relaxation velocities detsrmined 
by PWDTI pdor to, dudng, and following successful treatment from HTR at 
the time of EB, PEV were measured from the short axis view of the infere- 
postedor wall by PWDTI (Acucon XPot28), Results: There was a significant 
reduction in PEV dudng HTR from 0,196 :E 0,021 to 0,120 d: 0,029 m/sac,; 
p < 0,0001 with subsequent normalization following successful trea~nest to 
0.184 :~ 0,036 rn/sec, p < 0.0001 (see graph). Furthermore, a PEV of >0.15 
nYs has a negative predictive value of 95% to exclude rejection, a sanS~ 
of 92% and specificity of 60%. 
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Conolusion: HTR resulP, in a reduction in myocardial peak eady relaxation 
velocities. Hence, PWDTI may be a clinically useful noninvasive tool for the 
diagnosis of HTR and for following responses to therapy. 
~ N e o d  for Close Monitoring of Moderate Cardiac 
AIIograft Rejection ISHT 2 
Hans R Brunnsr-La Rocca, Gabor Suetsch, Jakob Schneider, 
Ferenc Follath, Wcifgang Kiowski. University Hospital, Cardiology, Zurich, 
Switzerland 
The natural course of rejection ISHT 2 is poody defined and the need for and 
interval between follow-up endon,~yocardial biopsies (EMB) am nor clear, 
Thsrefore, we analysed all EMB (n = 2868) from 161 transplant patients 
(mean age 47.7 :E 12.2 years, 148 mal~) on triple drug immunusuppressico 
since the introdu~on of the ISHT-ncmanciature at our institute. EMB were 
performed from day 3 up to 8,9 years after lransplantation (tx; median 197 
days). 374 episodes with ISHT 2 rejection were detected and had a fcilow- 
up EMB 7 to 10 days later without Change Of immunosuppression. ISHT 2 
rejection progressed (ISHT > 3A) in 67 (19.0%), persisted (ISHT 2) in 78 
(22.1%) and regressed (ISHT _< IB) in 208 rases (58.9%). In comparison, 
1884 scheduled EMB which were not follow-up EMB showed ISHT ~> 3A in 
145 (7,7%), ISHT 2 in 224 (11,9%) and ISHT .< 1B in 1515 (80.4%) cases (p < 
0.0001 ). The odds ratio (OR) for rejection ISHT >_ 3A 7 to 10 days after ISHT 
2 rejection was 2,81. This was highest at month 2 after tx (OR = 6.43, p < 
0.0001 ), lowest at month 5 (OR = 1,43, n.s,) and remained elevated latsr than 
one year after tx (OR = 3.88, p < 0,0001). Multivariate logistic regression 
analysis including most known risk factors for graft rejection showed that 
ISHT 2 rejection on previous EMB independently predicted rejection ISHT > 
3A and remained the most important dsk factor for rejection ISHT _> 3A (OR 
= 2,40, p < 0,0001) even late (> 1 year) after Ix (OR ,, 3.55, p = 0.001). 
Conclusion: These findings suggest hat moderate rejection ISHT 2 pro- 
gresses to higher grade of rejection in a considerable number of patients and 
close monitoflng :.,,alns necessary even late after tx, 
~ Non.lnvoslve Detection of Cardiac AIIograft 
Rejection bY Multiva_rlate Analys!s of Computer 
Qenemtad M-Moae oata In Pediatric Pat!onto 
Andrew J, Maxwell, Daniel Bemalain. Stanford University, Stanford, CA 
The aim of this study was to determine ifa computer program, dP"-'~ed to 
analyze echo~rdiographic M-Modes, could predict allogreft rejectloi~. Seflal 
echocardiograms (n= 7~,) were pelfermed in 5 patients, each within 24 hours 
of RV endomyocardlal biopsy. M-Modes wefe digltalized and retrospectivaly 
analyzed by a computer program designed to curve-tit he inner and outer 
posterior wall and both edgas of the ssptum averaged over 4 tO 7 cardiac 
cycles, Manipulation of the equations describing these curves produced 47 
data values of distances, volumes, rates of change and time pefinds from 
each M-Mode analysis. The collective datum were analysed for osrraiation 
with btupsy results (no evidence of rejection (N), ISHLT grades I and II (M), 
grades III and IV (S)) after conversion to individual Z scores. D~Ja was 
subjected to Hierarchical Discdminata Fun~ico Analysis (HDFA) designed 
to minimize Wilks' Lamlxla. HDFA produces a set of classification equations 
which assigns cases to rejection groups and additionally preduce~ a Csntreid 
Mop giving visual information on the reliability of any one assignment, HDFA 
resulted in several combinations of vadables and cosfficien~ producing 
sfgniticance (p < 0.001) between the three rejection groups. Cross-validation 
resulted in a sensitivity to defect aPy rejection of 0.89, to detect M of 0,74, 
and to detect S of 0.78 (specificity = 0.86). The positive predictive value for 
M = 41% ~,nd S = 64%. Misessigned cases plotted on the Centmid Map in 
locations uspicious for reliability. 
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We conclude this program, in conjunction with HDFA, is useful in predicting 
mild and severe rejection. 
~ Protective Effects of Complement Blockade In an 
Isograft Model of Lung Preservation and 
Transplantation 
Yoshitumi Naka, Dilip K. Roy, Henry C. Marsh t, Susanne M. Scosney ~, 
Una S. Ryan, David M. Stem, Hui Liao, Robert E. Michler, Mehmet C. Oz, 
David J. Piasky. Columbia University, New York, NY; 1 T Cell Sciences, 
Needham, MA 
Agents which inhibit complement activation protect against myocardial repot- 
fusion injun/and may be beneficial in xenotranaplantalJon, but it is not known 
whether complement activation is deletadous following lung preservation 
and transplantation i an isograft model. Lungs harvested from Lewis rata 
subjected to 4 ¢ C 6 hour preservation in Euro-Collins solution followed by 
transplantation i to Lewis recipiel~ts demonstrated increased immunostaln- 
Ing for C5b-9 cOmpared with nontransplanted controls, confirming local com- 
plement activation in this model. To inveStigate the physiologic relevance of 
complement a~vation in the trans;~lanted lung, the native pulmonary artery 
(PA) was ligated following transplanta~o~, and pulmonary vascular resis. 
tance (PVR, mm Hg/ml/mln), PA flow (PAl=, ml/mln), artedal oxygenation 
(.o02, mm Hg), graft neutrephil nfiltration (myeloparexJdese act~ty, MPO, 
~Abs 460 nnVmin), and recipient survival (Surv, %) were measured at 30 
minutes. Animals received either saline (control; n = 12) or soluble comple- 
ment receptor typ~-I (sCRt, 15 ms/ks, serum level range 127-355 p.g/ml by 
ELISA; n ,= 9) 2 minutes pdor to reperfusion, sCR1 treated animals showed 
a marked reduction in serum complement activity (CHS0 90% lower than 
control animals, p < 0.gg01). 
PVR PAF pO2 MPO SuP/ 
Control 8.5.4-1.5 4.94- 2.8 1254- 38 3.2:1:0.2 23% 
sCR1 2.9:1:1.1" 17.4i3.4" 1944-34 2,1 4-0.21" 74%t 
'~ p < O,05;l"p < 0,005 
In parallel with the reduction in CH50 in sCRI treated animals, Immunohis- 
tology revealed decreased C5b-9 deposition conlpared with confi'ols. Taken 
together, these data indicate that local complement activation occurs fol- 
lowing lung preservation and Imnaplantatlon i  an isograft model, and that 
inhibiting complement improves outcome to[lowing transplantation. 
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~ Snare-Asslstod Delivery for Transcathotar Coil 
Occlusion of Ductus Arteriosus 
Robert J. Sommer, Frank F. In(]. Mount Sinai Medical Center, New York, IVY 
Schneider Children's Hospital, New York, N~ Texas Children's Hospital, 
Houston, TX 
Transartedal and transvenous techniques for transcatheter occlusion of small 
patent ductus arteriosus (PDA) u:;ing a Gtanturco coil (GC) have been com- 
plicated by GC embolization to the pulmonary and systemic /rcutation, by 
